The superoxide dismutase mimetic, tempol, reduces the bioavailability of nitric oxide and does not alter L-NAME-induced hypertension in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 1, 2005, Pages 29-34

  Preti, Silvio César ^a   Da Cunha, Valdeci ^b   Vassallo, Dalton Valentim ^a   Stefanon, Ivanita ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING;

ANIMALS; AORTA; BIOLOGICAL AVAILABILITY; BLOOD PRESSURE; CYCLIC N-OXIDES; ENDOTHELIUM, VASCULAR; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; RATS; RATS, WISTAR; SPIN LABELS; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 21244447429     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_97105.x     Document Type: Article

References (30)

1. Bouloumié, A., J. Bauersachs, W. Linz, A. Schölkens, G. Wiemer, I. Fleming & R. Busse: Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 1997, 30, 934-941.
2. Bulpitt, C. J.: Vitamin C and blood pressure. J. Hypertension 1990, 8, 1071-1075.
3. 2 counteract the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Amer. J. Physiol. 2003, 285, R827-R833.
4. Cunha, R. S., A. M. Cabral & E. C. Vasquez: Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Amer. J. Hypertension 1993, 6, 806-809.
5. D'Amours, M., M. Lebel, J. Grose & R. Larivière: Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II. Can. J. Physiol. Pharmacol. 1999, 77, 8-16.
6. Da Cunha, V., L.V. Rossoni, A. Oliveira, S.P. Poton, S.C. Preti, D.V. Vassallo & I. Stefanon: Cyclooxygenase inhibition reduces blood pressure elevation and vascular reactivity dysfunction caused by inhibition of nitric oxide synthase in rats. Clin. Exp. Hypertension 2000, 22, 203-215.
7. Dobrian, A. D., S. D. Schriver & R. L. Prewitt: Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 2001, 38, 361-366.
8. Dos Santos, L., F. E. Xavier, D. V. Vassallo & L. V. Rossoni: Cycloxygenase pathway is involved in the vascular reactivity and inhibition of the Na(+), K(+)-ATPase activity in the tail artery from L-NAME-treated rats. Life Sci. 2003, 74, 613-627.
9. Gardiner, S. M., A. M. Compton, T. Bennet, R. M. J. Palmer & S. Moncada: Regional haemodynamic during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Brit. J. Pharmacol. 1990, 101, 625-631.
10. Gonzalez, W., V. Fontaine, M. E. Pueyo, N. Laquay, D Messika-Zeitoun, M. Philippe, J. F. Arnal, M. P. Jacob & J. B. Michel: Molecular plasticity of vascular wall during N(G)-nitro-L-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 2000, 36, 103-109.
11. Kerr, S., J. Brosnan, M. Mcintyre, J. L. Reid, A. F. Dominiczak & C. A. Hamilton: Superoxide anion production is increased in a model of genetic hypertension. Hypertension 1999, 33, 1353-1358.
12. Kitamoto, S., K. Egashira, C. Kataoka, M. Usui, M. Koyanagi, M. Takemoto & A. Takeshita: Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J. Hypertension 2000, 12, 1795-800.
13. Lahera, V., M. G. Salom, F. Miranda-Guardiola, S. Moncada & J. C. Romero: Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Amer. J. Physiol. 1991, 261, 1033-1037.
14. Mitchell, J. B., A. Samuni, M. C. Krishna, W. G. Degraff, M. S. Ahn, U. Samuni & A. Russo: Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990, 29, 2802-2807.
15. Ortiz, M. C., M. C. Manriquez, J. C. Romero & L. A. Juncos: Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 2001, 38, 655-659.
16. Rajagopalan, S., S. Kurz, T. Munzel, M. Tarpey, B. A. Freeman, K. K. Griendling & D. G. Harrison: Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J. Clin. Invest. 1996, 97, 1916-1923.
17. Ribeiro, M. O., E. Antunes, G. De Nucci, S. M. Lovisolo & R. Zatz: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992, 20, 298-303.
18. Rodriguez-Martínez, M., E. C. García-Cohen, A. B. Baena, R. González, M. Salaíces & J. Marín: Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Brit. J. Pharmacol. 1998, 125, 1329-1335.
19. Rossoni, L. V., L. Dos Santos, L. A. Barker & D. V. Vassallo: Ouabain changes arterial blood pressure and vascular reactivity to phenylephrine in L-NAME-induced hypertension. J. Cardiovasc. Pharmacol. 2003, 41, 105-116.
20. th Scientific Meeting of the International Society of Hypertension. 1998, Amsterdam, Holanda, 23, P 12.44.
21. Schnackenberg, C. G., W. J. Welch & C. S. Wilcox: Normalization of blood pressure and renal vascular resistance in SHR with a membrane permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 1998, 32, 59-64.
22. 2 alpha. Hypertension 1999, 33, 424-428.
23. Shastri, S., V. Gopalakrishnan, R. Poduri & H. D. Wang: Tempol selectively attenuate angiotensin II evoked vasoconstrictor responses in spontaneously hypertensive rats. J. Hypertension 2002, 20, 1381-1391.
24. Shokoji, T., A. Nishiyama, Y. Fujisawa, H. Hitomi, H. Kiyomoto, N. Takahashi, S. Kimura, M. Kohono & A. Youichi: Renal sympathetic nerve response to tempol in spontaneously hypertensive rats. Hypertension 2003, 41, 266-73.
25. Usui, M., K. Egashira, S. Kitamoto, M. Koyanagi, M. Katoh, C. Kataoka, H. Shimokawa & A. Takeshita: Pathogenic role of oxidative stress in vascular angiotensin-converting enzyme activation in long-term blockade of nitric oxide synthesis in rats. Hypertension 1999, 34, 546-51.
26. Vasquez, E. C., R. S. Cunha & A. M. Cabral: Baroreceptor reflex function in rats submitted to chronic inhibition of nitric oxide synthesis. Braz. J. Medical Biol. Res. 1994, 27, 767-774.
27. Vega, G. W., M. I. Roson, A. Bellver, M. M. Celentano & I. J. De La Riva: Nitric oxide and superoxide anions in vascular reactivity of renovascular hypertensive rats. Clin. Exp.l Hypertension 1995, 17, 817-835.
28. Zatz, R. & G. De Nucci: Effect of acute nitric oxide inhibition on glomerular microcirculation. Amer. J. Physiology 1991, 261, 360-363.
29. Zhang, Y., R. Jang, T. A. Mon, K. D. Croft, C. G. Schyvens, K. U. & J. A. Whitworth: The anti-oxidant Tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J. Hypertension 2003, 21, 1513-1518.
30. Zheng, J. S., X. Q. Yang, K. J. Lookingland, G. D. Fink, C. Hesslinger, G. Kapatos, I. Kovesdi & A. F. Chen: Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 2003, 108, 1238-1245.